ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Varicella Vaccine Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031
Published Date: May 2025
|
Report Code: QYRE-Auto-37D11956
Home | Market Reports | Health| Health Conditions| Infectious Diseases
Global Varicella Vaccine Market Size Manufacturers Supply Chain Sales Channel and Clients 2022 2028
BUY CHAPTERS

Global Varicella Vaccine Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031

Code: QYRE-Auto-37D11956
Report
May 2025
Pages:135
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Merck
GSK
Shanghai Institute
BCHT
Changsheng
Keygen
Green Cross
Biken

Varicella Vaccine Market Size

In 2024, the global market size of Varicella Vaccine was estimated to be worth US$ 4845 million and is forecast to reach approximately US$ 8137 million by 2031 with a CAGR of 7.8% during the forecast period 2025-2031.

Varicella Vaccine Market

Varicella Vaccine Market

Varicella vaccine, also known as chickenpox vaccine, is a vaccine that protects against chickenpox. One dose of vaccine prevents 95% of moderate disease and 100% of severe disease. Two doses of vaccine is more effective than one. If given to those who are not immune within five days of exposure to chickenpox it prevents most cases of disease. Vaccinating a large portion of the population also protects those who are not vaccinated. It is given by injection just under the skin
Global Varicella Vaccine key players include Merck, Shanghai Institute, Changsheng, Keygen, GSK, etc.
Asia is the largest market, with a share over 35%, followed by US and Europe, both have a share over 55%.
In terms of product, Freeze-Dried Powder is the largest segment, with a share over 50%. And in terms of application, the largest application is Kids Injection, followed by Adults Injection, etc.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Varicella Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Varicella Vaccine.
The Varicella Vaccine market size, estimations, and forecasts are provided in terms of sales volume (M Doses) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Varicella Vaccine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Varicella Vaccine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and regions.

Scope of Varicella Vaccine Market Report

Report Metric Details
Report Name Varicella Vaccine Market
Forecasted market size in 2031 approximately US$ 8137 million
CAGR 7.8%
Forecasted years 2025 - 2031
Segment by Type
  • Injection
  • Freeze-Dried Powder
Segment by Application
  • Kids Injection
  • Adults Injection
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Merck, GSK, Shanghai Institute, BCHT, Changsheng, Keygen, Green Cross, Biken
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Sales (consumption), revenue of Varicella Vaccine in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
  • Chapter 3: Detailed analysis of Varicella Vaccine manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Varicella Vaccine sales, revenue, price, gross margin, sales by region, by Type, by Application, and recent development, etc.
  • Chapter 5: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 6: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 7: North America by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 8: APAC by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 9: Europe by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 10: Latin America by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 11: Middle East and Africa by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
  • Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 14: Research Findings and Conclusion.

FAQ for this report

What is the Varicella Vaccine Market size in 2031?

Ans: The Varicella Vaccine Market size in 2031 will be approximately US$ 8137 million.

What is the Varicella Vaccine Market share by type?

Ans: In terms of product, Freeze-Dried Powder is the largest segment, with a share over 50%.

Who are the main players in the Varicella Vaccine Market report?

Ans: The main players in the Varicella Vaccine Market are Merck, GSK, Shanghai Institute, BCHT, Changsheng, Keygen, Green Cross, Biken

What are the Application segmentation covered in the Varicella Vaccine Market report?

Ans: The Applications covered in the Varicella Vaccine Market report are Kids Injection, Adults Injection

What are the Type segmentation covered in the Varicella Vaccine Market report?

Ans: The Types covered in the Varicella Vaccine Market report are Injection, Freeze-Dried Powder

Recommended Reports

Pediatric Vaccines

Varicella & Pox Vaccines

Flu and Viral Vaccines

Market trends :

Topic Trends
Global the global varicella vaccine market is experiencing robust growth driven by increasing immunization coverage, rising awareness of vaccine-preventable diseases, and strong demand for pediatric vaccination programs.
Type Injection - injection-based varicella vaccines remain widely adopted due to established administration protocols and healthcare provider familiarity.
Freeze-Dried Powder - freeze-dried powder varicella vaccines lead the market segment with over 50% share, favored for stability and ease of transport.
Application Kids Injection - kids injection dominates application segments as pediatric immunization programs drive the majority of varicella vaccine demand globally.
Adults Injection - adults injection sees steady growth as awareness of adult varicella vaccination increases, particularly in regions with catch-up immunization policies.
Company Merck - merck continues to maintain a leading position in the varicella vaccine market through established distribution networks and ongoing product availability in major regions.
GSK - gsk leverages its global presence and diversified vaccine portfolio to strengthen its market share in the varicella vaccine segment.
Shanghai Institute - shanghai institute benefits from strong demand in asia, contributing significantly to regional market expansion for varicella vaccines.
BCHT - bcht focuses on expanding production capacity to meet increasing domestic and export demand for varicella vaccines.
Changsheng - changsheng targets growth in the apac region by enhancing its product offerings and distribution channels for varicella vaccines.
Keygen - keygen is capitalizing on regional vaccination initiatives to boost sales of its varicella vaccine products.
Green Cross - green cross strengthens its presence in the apac market by leveraging local partnerships and regulatory approvals for varicella vaccines.
Biken - biken supports market growth through consistent supply and participation in regional immunization programs.
Region North America - north america maintains strong market growth due to high vaccination coverage and established healthcare infrastructure.
EMEA - emea region experiences steady demand for varicella vaccines, supported by national immunization schedules and public health initiatives.
APAC - apac leads global market share with over 35%, driven by large population base and expanding government vaccination programs.
LATAM - latam shows increasing adoption of varicella vaccines as regional health authorities prioritize immunization against vaccine-preventable diseases.
1 Study Coverage
1.1 Varicella Vaccine Product Introduction
1.2 Market by Type
1.2.1 Global Varicella Vaccine Market Size Growth Rate by Type (2020 VS 2024 VS 2031)
1.2.2 Injection
1.2.3 Freeze-Dried Powder
1.3 Market by Application
1.3.1 Global Varicella Vaccine Market Size Growth Rate by Application (2020 VS 2024 VS 2031)
1.3.2 Kids Injection
1.3.3 Adults Injection
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Varicella Vaccine Market Size Estimates and Forecasts
2.1.1 Global Varicella Vaccine Revenue 2020-2031
2.1.2 Global Varicella Vaccine Sales 2020-2031
2.2 Varicella Vaccine Market Size by Region: 2024 Versus 2031
2.3 Varicella Vaccine Sales by Region (2020-2031)
2.3.1 Global Varicella Vaccine Sales by Region: 2020-2025
2.3.2 Global Varicella Vaccine Sales Forecast by Region (2026-2031)
2.3.3 Global Varicella Vaccine Sales Market Share by Region (2020-2031)
2.4 Varicella Vaccine Market Estimates and Projections by Region (2026-2031)
2.4.1 Global Varicella Vaccine Revenue by Region: 2020-2025
2.4.2 Global Varicella Vaccine Revenue Forecast by Region (2026-2031)
2.4.3 Global Varicella Vaccine Revenue Market Share by Region (2020-2031)
3 Market Segments
3.1 Breakdown Data by Type
3.1.1 Global Varicella Vaccine Sales by Type (2020-2031)
3.1.1.1 Global Varicella Vaccine Sales Volume by Type (2020-2031)
3.1.1.2 Global Varicella Vaccine Sales Market Share by Type (2020-2031)
3.1.2 Global Varicella Vaccine Revenue by Type (2020-2031)
3.1.2.1 Global Varicella Vaccine Revenue by Type (2020-2031)
3.1.2.2 Global Varicella Vaccine Revenue Market Share by Type (2020-2031)
3.1.3 Varicella Vaccine Average Selling Price (ASP) by Type (2020-2031)
3.2 Breakdown Data by Application
3.2.1 Global Varicella Vaccine Sales by Application (2020-2031)
3.2.1.1 Global Varicella Vaccine Sales Volume by Application (2020-2031)
3.2.1.2 Global Varicella Vaccine Sales Market Share by Application (2020-2031)
3.2.2 Global Varicella Vaccine Revenue by Application (2020-2031)
3.2.2.1 Global Varicella Vaccine Revenue by Application (2020-2031)
3.2.2.2 Global Varicella Vaccine Revenue Market Share by Application (2020-2031)
3.2.3 Varicella Vaccine Average Selling Price (ASP) by Application (2020-2031)
3.3 by Type and by Application Crossing Analysis
3.3.1 Injection of Varicella Vaccine Revenue Market Share by Application
3.3.2 Freeze-Dried Powder of Varicella Vaccine Revenue Market Share by Application
4 Global Varicella Vaccine by Manufacturers
4.1 Global Top Varicella Vaccine Manufacturers by Sales (2020-2025)
4.1.1 Global Varicella Vaccine Sales by Manufacturer (2020-2025)
4.1.2 Global Varicella Vaccine Sales Market Share by Manufacturer (2020-2025)
4.2 Global Top Varicella Vaccine Manufacturers by Revenue (2020-2025)
4.2.1 Global Varicella Vaccine Revenue by Manufacturer (2020-2025)
4.2.2 Global Varicella Vaccine Revenue Share by Manufacturer (2020-2025)
4.3 Global Varicella Vaccine Price by Manufacturer (2020-2025)
4.4 Competitive Landscape
4.4.1 Key Varicella Vaccine Manufacturers Covered: Ranking by Revenue
4.4.2 Global Varicella Vaccine Market Concentration Ratio (CR5 and HHI) & (2020-2025)
4.4.3 Global Varicella Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.5 Global Varicella Vaccine Manufacturing Base Distribution, Product Type
4.5.1 Varicella Vaccine Manufacturers Manufacturing Base Distribution, Headquarters
4.5.2 Date of International Manufacturers Enter into Varicella Vaccine Market
4.5.3 Manufacturers Varicella Vaccine Product Type and Application
4.5.4 Injection Market Sales of Varicella Vaccine by Manufacturer
4.5.5 Freeze-Dried Powder Market Sales of Varicella Vaccine by Manufacturer
4.6 Manufacturers Mergers & Acquisitions, Expansion Plans
5 Company Profiles
5.1 Merck
5.1.1 Merck Company Information
5.1.2 Merck Description, Business Overview
5.1.3 Merck Varicella Vaccine Products Offered
5.1.4 Merck Varicella Vaccine Sales, Revenue and Gross Margin (2020-2025)
5.1.5 Merck Varicella Vaccine Sales by Product in 2024
5.1.6 Merck Varicella Vaccine Sales by Application in 2024
5.1.7 Merck Varicella Vaccine Sales by Geographic Area in 2024
5.1.8 Merck Recent Developments
5.2 GSK
5.2.1 GSK Company Information
5.2.2 GSK Description, Business Overview
5.2.3 GSK Varicella Vaccine Products Offered
5.2.4 GSK Varicella Vaccine Sales, Revenue and Gross Margin (2020-2025)
5.2.5 GSK Varicella Vaccine Sales by Product in 2024
5.2.6 GSK Varicella Vaccine Sales by Application in 2024
5.2.7 GSK Varicella Vaccine Sales by Geographic Area in 2024
5.2.8 GSK Recent Developments
5.3 Shanghai Institute
5.3.1 Shanghai Institute Company Information
5.3.2 Shanghai Institute Description, Business Overview
5.3.3 Shanghai Institute Varicella Vaccine Products Offered
5.3.4 Shanghai Institute Varicella Vaccine Sales, Revenue and Gross Margin (2020-2025)
5.3.5 Shanghai Institute Varicella Vaccine Sales by Product in 2024
5.3.6 Shanghai Institute Varicella Vaccine Sales by Application in 2024
5.3.7 Shanghai Institute Varicella Vaccine Sales by Geographic Area in 2024
5.3.8 Shanghai Institute Recent Developments
5.4 BCHT
5.4.1 BCHT Company Information
5.4.2 BCHT Description, Business Overview
5.4.3 BCHT Varicella Vaccine Products Offered
5.4.4 BCHT Varicella Vaccine Sales, Revenue and Gross Margin (2020-2025)
5.4.5 BCHT Varicella Vaccine Sales by Product in 2024
5.4.6 BCHT Varicella Vaccine Sales by Application in 2024
5.4.7 BCHT Varicella Vaccine Sales by Geographic Area in 2024
5.4.8 BCHT Recent Developments
5.5 Changsheng
5.5.1 Changsheng Company Information
5.5.2 Changsheng Description, Business Overview
5.5.3 Changsheng Varicella Vaccine Products Offered
5.5.4 Changsheng Varicella Vaccine Sales, Revenue and Gross Margin (2020-2025)
5.5.5 Changsheng Varicella Vaccine Sales by Product in 2024
5.5.6 Changsheng Varicella Vaccine Sales by Application in 2024
5.5.7 Changsheng Varicella Vaccine Sales by Geographic Area in 2024
5.5.8 Changsheng Recent Developments
5.6 Keygen
5.6.1 Keygen Company Information
5.6.2 Keygen Description, Business Overview
5.6.3 Keygen Varicella Vaccine Products Offered
5.6.4 Keygen Varicella Vaccine Sales, Revenue and Gross Margin (2020-2025)
5.6.5 Keygen Varicella Vaccine Sales by Product in 2024
5.6.6 Keygen Varicella Vaccine Sales by Application in 2024
5.6.7 Keygen Varicella Vaccine Sales by Geographic Area in 2024
5.6.8 Keygen Recent Developments
5.7 Green Cross
5.7.1 Green Cross Company Information
5.7.2 Green Cross Description, Business Overview
5.7.3 Green Cross Varicella Vaccine Products Offered
5.7.4 Green Cross Varicella Vaccine Sales, Revenue and Gross Margin (2020-2025)
5.7.5 Green Cross Varicella Vaccine Sales by Product in 2024
5.7.6 Green Cross Varicella Vaccine Sales by Application in 2024
5.7.7 Green Cross Varicella Vaccine Sales by Geographic Area in 2024
5.7.8 Green Cross Recent Developments
5.8 Biken
5.8.1 Biken Company Information
5.8.2 Biken Description, Business Overview
5.8.3 Biken Varicella Vaccine Products Offered
5.8.4 Biken Varicella Vaccine Sales, Revenue and Gross Margin (2020-2025)
5.8.5 Biken Varicella Vaccine Sales by Product in 2024
5.8.6 Biken Varicella Vaccine Sales by Application in 2024
5.8.7 Biken Varicella Vaccine Sales by Geographic Area in 2024
5.8.8 Biken Recent Developments
6 North America
6.1 North America Varicella Vaccine Market Size YoY Growth 2020-2031
6.2 North America Varicella Vaccine Market Facts & Figures by Country
6.2.1 North America Varicella Vaccine Sales by Country (2020-2031)
6.2.2 North America Varicella Vaccine Revenue by Country (2020-2031)
6.3 North America Varicella Vaccine Sales by Type (2020-2025)
6.4 North America Varicella Vaccine Sales by Application (2020-2025)
7 Asia-Pacific
7.1 Asia-Pacific Varicella Vaccine Market Size YoY Growth 2020-2031
7.2 Asia-Pacific Varicella Vaccine Market Facts & Figures by Region
7.2.1 Asia-Pacific Varicella Vaccine Sales by Region (2020-2031)
7.2.2 Asia-Pacific Varicella Vaccine Revenue by Region (2020-2031)
7.3 Asia-Pacific Varicella Vaccine Sales by Type (2020-2025)
7.4 Asia-Pacific Varicella Vaccine Sales by Application (2020-2025)
8 Europe
8.1 Europe Varicella Vaccine Market Size YoY Growth 2020-2031
8.2 Europe Varicella Vaccine Market Facts & Figures by Country
8.2.1 Europe Varicella Vaccine Sales by Country (2020-2031)
8.2.2 Europe Varicella Vaccine Revenue by Country (2020-2031)
8.3 Europe Varicella Vaccine Sales by Type (2020-2025)
8.4 Europe Varicella Vaccine Sales by Application (2020-2025)
9 Latin America
9.1 Latin America Varicella Vaccine Market Size YoY Growth 2020-2031
9.2 Latin America Varicella Vaccine Market Facts & Figures by Country
9.2.1 Latin America Varicella Vaccine Sales by Country (2020-2031)
9.2.2 Latin America Varicella Vaccine Revenue by Country (2020-2031)
9.3 Latin America Varicella Vaccine Sales by Type (2020-2025)
9.4 Latin America Varicella Vaccine Sales by Application (2020-2025)
10 Middle East and Africa
10.1 Latin America Varicella Vaccine Market Size YoY Growth 2020-2031
10.2 Middle East and Africa Varicella Vaccine Market Facts & Figures by Country
10.2.1 Middle East and Africa Varicella Vaccine Sales by Country (2020-2031)
10.2.2 Middle East and Africa Varicella Vaccine Revenue by Country (2020-2031)
10.3 Middle East and Africa Varicella Vaccine Sales by Type (2020-2025)
10.4 Middle East and Africa Varicella Vaccine Sales by Application (2020-2025)
11 Supply Chain and Sales Channel analysis
11.1 Varicella Vaccine Supply Chain Analysis
11.2 Varicella Vaccine Key Raw Materials and Upstream Suppliers
11.3 Varicella Vaccine Clients Analysis
11.4 Varicella Vaccine Sales Channel and Sales Model Analysis
11.4.1 Varicella Vaccine Distribution Channel Analysis: Indirect Sales VS Direct Sales
11.4.2 Varicella Vaccine Distribution Channel Analysis: Online Sales VS Offline Sales
11.4.3 Varicella Vaccine Distributors
12 Varicella Vaccine Market Dynamics
12.1 Varicella Vaccine Industry Trends
12.2 Varicella Vaccine Market Drivers
12.3 Varicella Vaccine Market Challenges
12.4 Varicella Vaccine Market Restraints
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
FEATURED COMPANIES
Merck
GSK
Shanghai Institute
BCHT
Changsheng
Keygen
Green Cross
Biken
List of Tables
 Table 1. Global Varicella Vaccine Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Global Varicella Vaccine Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 3. Global Varicella Vaccine Market Size by Region (US$ Million): 2024 VS 2031
 Table 4. Global Varicella Vaccine Sales by Region (2020-2025) & (M Doses)
 Table 5. Global Varicella Vaccine Sales Forecast by Region (2026-2031) & (M Doses)
 Table 6. Global Varicella Vaccine Revenue by Region (2020-2025) & (US$ Million)
 Table 7. Global Varicella Vaccine Revenue Forecast by Region (2026-2031) & (US$ Million)
 Table 8. Global Varicella Vaccine Sales Volume by Type (2020-2025) & (M Doses)
 Table 9. Global Varicella Vaccine Sales Volume by Type (2026-2031) & (M Doses)
 Table 10. Global Varicella Vaccine Revenue by Type (2020-2025) & (US$ Million)
 Table 11. Global Varicella Vaccine Revenue Forecast by Type (2026-2031) & (US$ Million)
 Table 12. Global Varicella Vaccine Sales Volume by Application (2020-2025) & (M Doses)
 Table 13. Global Varicella Vaccine Sales Volume by Application (2026-2031) & (M Doses)
 Table 14. Global Varicella Vaccine Revenue by Application (2020-2025) & (US$ Million)
 Table 15. Global Varicella Vaccine Revenue by Application (2026-2031) & (US$ Million)
 Table 16. Global Varicella Vaccine Sales by Manufacturer (2020-2025) & (M Doses)
 Table 17. Global Varicella Vaccine Sales Share by Manufacturer (2020-2025)
 Table 18. Varicella Vaccine Revenue by Manufacturer (2020-2025) & (US$ Million)
 Table 19. Varicella Vaccine Revenue Share by Manufacturer (2020-2025)
 Table 20. Key Manufacturers Varicella Vaccine Price (2020-2025) & (USD/Dose)
 Table 21. Ranking of Global Top Varicella Vaccine Manufacturers by Revenue (US$ Million) in 2024
 Table 22. Global Varicella Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI) & (2020-2025)
 Table 23. Global Varicella Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Varicella Vaccine as of 2024)
 Table 24. Varicella Vaccine Manufacturers Manufacturing Base Distribution and Headquarters
 Table 25. Date of International Manufacturers Enter into Varicella Vaccine Market
 Table 26. Manufacturers Varicella Vaccine Product Type and Application
 Table 27. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 28. Merck Company Information
 Table 29. Merck Description and Business Overview
 Table 30. Merck Varicella Vaccine Product
 Table 31. Merck Varicella Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)
 Table 32. Merck Sales Proportion of Varicella Vaccine by Product in 2024
 Table 33. Merck Sales Proportion of Varicella Vaccine by Application in 2024
 Table 34. Merck Sales Proportion of Varicella Vaccine by Geographic Area in 2024
 Table 35. Merck Recent Developments
 Table 36. GSK Company Information
 Table 37. GSK Description and Business Overview
 Table 38. GSK Varicella Vaccine Product
 Table 39. GSK Varicella Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)
 Table 40. GSK Sales Proportion of Varicella Vaccine by Product in 2024
 Table 41. GSK Sales Proportion of Varicella Vaccine by Application in 2024
 Table 42. GSK Sales Proportion of Varicella Vaccine by Geographic Area in 2024
 Table 43. GSK Recent Developments
 Table 44. Shanghai Institute Company Information
 Table 45. Shanghai Institute Description and Business Overview
 Table 46. Shanghai Institute Varicella Vaccine Product
 Table 47. Shanghai Institute Varicella Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)
 Table 48. Shanghai Institute Sales Proportion of Varicella Vaccine by Product in 2024
 Table 49. Shanghai Institute Sales Proportion of Varicella Vaccine by Application in 2024
 Table 50. Shanghai Institute Sales Proportion of Varicella Vaccine by Geographic Area in 2024
 Table 51. Shanghai Institute Recent Developments
 Table 52. BCHT Company Information
 Table 53. BCHT Description and Business Overview
 Table 54. BCHT Varicella Vaccine Product
 Table 55. BCHT Varicella Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)
 Table 56. BCHT Sales Proportion of Varicella Vaccine by Product in 2024
 Table 57. BCHT Sales Proportion of Varicella Vaccine by Application in 2024
 Table 58. BCHT Sales Proportion of Varicella Vaccine by Geographic Area in 2024
 Table 59. BCHT Recent Developments
 Table 60. Changsheng Company Information
 Table 61. Changsheng Description and Business Overview
 Table 62. Changsheng Varicella Vaccine Product
 Table 63. Changsheng Varicella Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)
 Table 64. Changsheng Sales Proportion of Varicella Vaccine by Product in 2024
 Table 65. Changsheng Sales Proportion of Varicella Vaccine by Application in 2024
 Table 66. Changsheng Sales Proportion of Varicella Vaccine by Geographic Area in 2024
 Table 67. Changsheng Recent Developments
 Table 68. Keygen Company Information
 Table 69. Keygen Description and Business Overview
 Table 70. Keygen Varicella Vaccine Product
 Table 71. Keygen Varicella Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)
 Table 72. Keygen Sales Proportion of Varicella Vaccine by Product in 2024
 Table 73. Keygen Sales Proportion of Varicella Vaccine by Application in 2024
 Table 74. Keygen Sales Proportion of Varicella Vaccine by Geographic Area in 2024
 Table 75. Keygen Recent Developments
 Table 76. Green Cross Company Information
 Table 77. Green Cross Description and Business Overview
 Table 78. Green Cross Varicella Vaccine Product
 Table 79. Green Cross Varicella Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)
 Table 80. Green Cross Sales Proportion of Varicella Vaccine by Product in 2024
 Table 81. Green Cross Sales Proportion of Varicella Vaccine by Application in 2024
 Table 82. Green Cross Sales Proportion of Varicella Vaccine by Geographic Area in 2024
 Table 83. Green Cross Recent Developments
 Table 84. Biken Company Information
 Table 85. Biken Description and Business Overview
 Table 86. Biken Varicella Vaccine Product
 Table 87. Biken Varicella Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)
 Table 88. Biken Sales Proportion of Varicella Vaccine by Product in 2024
 Table 89. Biken Sales Proportion of Varicella Vaccine by Application in 2024
 Table 90. Biken Sales Proportion of Varicella Vaccine by Geographic Area in 2024
 Table 91. Biken Recent Developments
 Table 92. North America Varicella Vaccine Sales by Country (2020-2025) & (M Doses)
 Table 93. North America Varicella Vaccine Sales by Country (2026-2031) & (M Doses)
 Table 94. North America Varicella Vaccine Revenue by Country (2020-2025) & (US$ Million)
 Table 95. North America Varicella Vaccine Revenue by Country (2026-2031) & (US$ Million)
 Table 96. North America Varicella Vaccine Sales by Type (2020-2025) & (M Doses)
 Table 97. North America Varicella Vaccine Sales by Application (2020-2025) & (M Doses)
 Table 98. Asia-Pacific Varicella Vaccine Sales by Region (2020-2025) & (M Doses)
 Table 99. Asia-Pacific Varicella Vaccine Sales by Region (2026-2031) & (M Doses)
 Table 100. Asia-Pacific Varicella Vaccine Revenue by Region (2020-2025) & (US$ Million)
 Table 101. Asia-Pacific Varicella Vaccine Revenue by Region (2026-2031) & (US$ Million)
 Table 102. Asia-Pacific Varicella Vaccine Sales by Type (2020-2025) & (M Doses)
 Table 103. Asia-Pacific Varicella Vaccine Sales by Application (2020-2025) & (M Doses)
 Table 104. Europe Varicella Vaccine Sales by Country (2020-2025) & (M Doses)
 Table 105. Europe Varicella Vaccine Sales by Country (2026-2031) & (M Doses)
 Table 106. Europe Varicella Vaccine Revenue by Country (2020-2025) & (US$ Million)
 Table 107. Europe Varicella Vaccine Revenue by Country (2026-2031) & (US$ Million)
 Table 108. Europe Varicella Vaccine Sales by Type (2020-2025) & (M Doses)
 Table 109. Europe Varicella Vaccine Sales by Application (2020-2025) & (M Doses)
 Table 110. Latin America Varicella Vaccine Sales by Country (2020-2025) & (M Doses)
 Table 111. Latin America Varicella Vaccine Sales by Country (2026-2031) & (M Doses)
 Table 112. Latin America Varicella Vaccine Revenue by Country (2020-2025) & (US$ Million)
 Table 113. Latin America Varicella Vaccine Revenue by Country (2026-2031) & (US$ Million)
 Table 114. Latin America Varicella Vaccine Sales by Type (2020-2025) & (M Doses)
 Table 115. Latin America Varicella Vaccine Sales by Application (2020-2025) & (M Doses)
 Table 116. Middle East and Africa Varicella Vaccine Sales by Country (2020-2025) & (M Doses)
 Table 117. Middle East and Africa Varicella Vaccine Sales by Country (2026-2031) & (M Doses)
 Table 118. Middle East and Africa Varicella Vaccine Revenue by Country (2020-2025) & (US$ Million)
 Table 119. Middle East and Africa Varicella Vaccine Revenue by Country (2026-2031) & (US$ Million)
 Table 120. Middle East and Africa Varicella Vaccine Sales by Type (2020-2025) & (M Doses)
 Table 121. Middle East and Africa Varicella Vaccine Sales by Application (2020-2025) & (M Doses)
 Table 122. Varicella Vaccine Key Raw Materials, Industry Status and Trend
 Table 123. Varicella Vaccine Key Raw Materials and Upstream Suppliers
 Table 124. Varicella Vaccine Clients Status and Trend
 Table 125. Varicella Vaccine Typical Clients
 Table 126. Varicella Vaccine Distributors
 Table 127. Varicella Vaccine Market Trends
 Table 128. Varicella Vaccine Market Drivers
 Table 129. Varicella Vaccine Market Challenges
 Table 130. Varicella Vaccine Market Restraints
 Table 131. Research Programs/Design for This Report
 Table 132. Key Data Information from Secondary Sources
 Table 133. Key Data Information from Primary Sources
 Table 134. QYR Business Unit and Senior & Team Lead Analysts


List of Figures
 Figure 1. Varicella Vaccine Product Picture
 Figure 2. Global Varicella Vaccine Market Size by Type (US$ Million): 2020 VS 2024 VS 2031
 Figure 3. Global Varicella Vaccine Sales Market Share by Type in 2024 & 2031
 Figure 4. Injection Product Picture
 Figure 5. Freeze-Dried Powder Product Picture
 Figure 6. Global Varicella Vaccine Market Size by Application (US$ Million): 2020 VS 2024 VS 2031
 Figure 7. Global Varicella Vaccine Sales Market Share by Application in 2024 & 2031
 Figure 8. Kids Injection
 Figure 9. Adults Injection
 Figure 10. Varicella Vaccine Report Years Considered
 Figure 11. Global Varicella Vaccine Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 12. Global Varicella Vaccine Market Size 2020-2031 (US$ Million)
 Figure 13. Global Varicella Vaccine Sales 2020-2031 (M Doses)
 Figure 14. Global Varicella Vaccine Sales Market Share Forecast by Region (2020-2031)
 Figure 15. Global Varicella Vaccine Revenue Market Share by Region (2020-2031)
 Figure 16. Global Varicella Vaccine Sales Market Share Forecast by Type (2020-2031)
 Figure 17. Global Varicella Vaccine Revenue Market Share Forecast by Type (2020-2031)
 Figure 18. Varicella Vaccine Average Selling Price (ASP) by Type (2020-2025) & (USD/Dose)
 Figure 19. Global Varicella Vaccine Sales Market Share Forecast by Application (2020-2031)
 Figure 20. Global Varicella Vaccine Revenue Market Share Forecast by Application (2020-2031)
 Figure 21. Varicella Vaccine Average Selling Price (ASP) by Application (2020-2025) & (USD/Dose)
 Figure 22. Injection of Varicella Vaccine Revenue Market Share by Application, 2024 VS 2031
 Figure 23. Freeze-Dried Powder of Varicella Vaccine Revenue Market Share by Application, 2024 VS 2031
 Figure 24. Global Varicella Vaccine Sales Share by Manufacturer in 2024
 Figure 25. Varicella Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 26. Injection Market Sales Proportion by Manufacturer in 2024
 Figure 27. Freeze-Dried Powder Market Sales Proportion by Manufacturer in 2024
 Figure 28. North America Varicella Vaccine Revenue 2020-2031 (US$ Million)
 Figure 29. North America Varicella Vaccine Sales Market Share by Type (2020-2025)
 Figure 30. North America Varicella Vaccine Sales Market Share by Application (2020-2025)
 Figure 31. Asia-Pacific Varicella Vaccine Revenue 2020-2031 (US$ Million)
 Figure 32. Asia-Pacific Varicella Vaccine Sales Market Share by Region (2020-2031)
 Figure 33. Asia-Pacific Varicella Vaccine Revenue Market Share by Region (2020-2031)
 Figure 34. Asia-Pacific Varicella Vaccine Sales Market Share by Type (2020-2025)
 Figure 35. Asia-Pacific Varicella Vaccine Sales Market Share by Application (2020-2025)
 Figure 36. Europe Varicella Vaccine Revenue Growth Rate 2020-2031 (US$ Million)
 Figure 37. Europe Varicella Vaccine Sales Market Share by Country (2020-2031)
 Figure 38. Europe Varicella Vaccine Revenue Market Share by Country (2020-2031)
 Figure 39. Europe Varicella Vaccine Sales Market Share by Type (2020-2025)
 Figure 40. Europe Varicella Vaccine Sales Market Share by Application (2020-2025)
 Figure 41. Latin America Varicella Vaccine Revenue Growth Rate 2020-2031 (US$ Million)
 Figure 42. Latin America Varicella Vaccine Sales Market Share by Country (2020-2031)
 Figure 43. Latin America Varicella Vaccine Revenue Market Share by Country (2020-2025)
 Figure 44. Latin America Varicella Vaccine Sales Market Share by Type (2020-2025)
 Figure 45. Latin America Varicella Vaccine Sales Market Share by Application (2020-2025)
 Figure 46. Middle East and Africa Varicella Vaccine Revenue Growth Rate 2020-2031 (US$ Million)
 Figure 47. Middle East and Africa Varicella Vaccine Sales Market Share by Country (2020-2031)
 Figure 48. Middle East and Africa Varicella Vaccine Revenue Market Share by Country (2020-2031)
 Figure 49. Middle East and Africa Varicella Vaccine Sales Market Share by Type (2020-2025)
 Figure 50. Middle East and Africa Varicella Vaccine Sales Market Share by Application (2020-2025)
 Figure 51. Varicella Vaccine Supply Chain (Upstream and Downstream Market)
 Figure 52. Global Production Market Share of Varicella Vaccine Raw Materials by Region in 2024
 Figure 53. Varicella Vaccine Distribution Channels
 Figure 54. Global Varicella Vaccine Percentage 2020-2031: Indirect Sales VS Direct Sales
 Figure 55. Global Varicella Vaccine Percentage 2020-2031: Online Sales VS Offline Sales
 Figure 56. Bottom-up and Top-down Approaches for This Report
 Figure 57. Data Triangulation
 Figure 58. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$5900

This license allows only one user to access the PDF.
Electronic (PDF)

$8850

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$11800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Nano String

SIMILAR REPORTS

Chickenpox Varicella Vaccine Market
Global Avian Pox Vaccine Market Research Report 2024
Global Poultry Vaccines Market Research Report 2025
Global Varicella Vaccination Market Research Report 2025
Chickenpox Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Varicella Live Vaccine Market Insights Forecast to 2030
Varicella Virus Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Varicella Virus Attenuated Live Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Live Attenuated Varicella Vaccine Market Research Report 2025
Global Varicella Attenuated Live Vaccination Market Research Report 2025
Global Varicella Attenuated Live Vaccine Market Research Report 2025
Global Monkeypox Vaccine Market Research Report 2025
Global Live Herpes Zoster Vaccine Market Research Report 2024
Global Live Attenuated Vaccine for Chickenpox Market Research Report 2025
Zoster Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Monkeypox Virus Vaccine Market Research Report 2024
Human Varicella Zoster Immunoglobulin Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Measles Mumps Rubella and Varicella Combined Vaccine Market Research Report 2024
Global Herpes Simplex Virus HSV Vaccines Market Insights Forecast to 2030
Global Flu Vaccination Market Research Report 2025
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions